Anticorps Monoclonal anti-ARL8A/ARL8B

ARL8A/ARL8B Monoclonal Antibody for WB, IF/ICC, Indirect ELISA

Hôte / Isotype

Mouse / IgG2a

Réactivité testée

Humain, Lapin, rat, souris

Applications

WB, IF/ICC, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

2F4C3

N° de cat : 68186-1-PBS

Synonymes

ARL8A, GIE2, ARL10B, ADP-ribosylation factor-like protein 8A, ADP-ribosylation factor-like protein 10B



Informations sur le produit

68186-1-PBS cible ARL8A/ARL8B dans les applications de WB, IF/ICC, Indirect ELISA et montre une réactivité avec des échantillons Humain, Lapin, rat, souris

Réactivité Humain, Lapin, rat, souris
Hôte / Isotype Mouse / IgG2a
Clonalité Monoclonal
Type Anticorps
Immunogène ARL8A/ARL8B Protéine recombinante Ag10758
Nom complet ADP-ribosylation factor-like 8A
Masse moléculaire calculée 186 aa, 21 kDa
Poids moléculaire observé18 kDa, 21 kDa
Numéro d’acquisition GenBankBC015408
Symbole du gène ARL8A
Identification du gène (NCBI) 127829
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

ARL8A (ADP-ribosylation factor-like protein 8A) is also named as ARL10B, GIE2 and belongs to the small GTPase superfamily. ARL8A is localized to lysosomes in mammalian cells (PMID: 16537643). In neurons, ARL8A mediates the anterograde axonal long-range transport of presynaptic lysosome-related vesicles that are required for presynaptic biogenesis and synaptic function. ARL8A is upregulated in many cancers such as endometrial cancer (PMID: 32070877), colorectal cancer (PMID: 30546056) and inflammatory breast cancer (PMID: 27648361), and has been associated with poor survival outcomes. ARL8A/ARL8B can be recognized by this antibody.

{{ptg:RelatedPrimaryAntibodies}}